In this study, we investigate the association between the tumor mutational burden (TMB) and clinical characteristics of HNSCC, as well as the impact of COL11A1 gene mutations on the immune microenvironment in head and neck cancer (HNC). This evidence concerns the gene COL11A1 and neoplasm.